For his innovation in the production and application of medical isotopes; for advancing the separation and purification of actinides and heavy elements; and for his leadership in the use of alpha emitters to save the lives of cancer patients.
For his broad scientific contributions and international reputation in aqueous chemistry and geochemistry; for his research into the structure, dynamics, and reactions at fluid–solid interfaces; and for his leadership and service to ORNL and the international scientific community.
Since 2001, Mike Simpson has been a group leader for the Nanofabrication Research Laboratory and theme leader in the Center for Nanophase Materials Sciences. His research focus includes noise biology, nano-enabled synthetic biology and controlled synthesis and directed assembly of carbon nanostructures.
For forefront studies of the fundamental science of actinide elements, through mendelevium, which employ novel experimental techniques, make systematic comparisons, and emphasize the role of the elements' electronic configurations.
For distinguished research in the field of risk assessment, including pharmacokinetic and pharmacodynamic models, interspecies extrapolation, and human exposure to dioxin and other background contaminants, and for significant contributions to environmental policy through pioneering investigations of the effectiveness of remediation technologies and through service on national and international advisory panels and boards
For outstanding contributions to many areas of solid-state physics, including the electronic structure of metals, ultrarapid melting and solidification phenomena, pulsed-laser deposition and epitaxial film growth, high-temperature superconductivity, and beam-assisted processing of thin films and superlattices.